The Fate of Factor VII and Stuart Factor During the Clotting of Normal Blood

Charles L Johnston jr.; John H Ferguson; Frieda A O’Hanlon; W. L Black

doi:10.1055/s-0038-1654397

Thrombosis and Haemostasis, Table of Contents

Thromb Haemost 1959; 03(03): 367-374
DOI: 10.1055/s-0038-1654397

Originalarbeiten — Original Articles — Travaux Originaux

Schattauer GmbH

The Fate of Factor VII and Stuart Factor During the Clotting of Normal Blood ^[*)]

Charles L Johnston jr.

¹Department of Physiology, University of North Carolina School of Medicine, Chapel Hill, N. C, USA

,

John H Ferguson

¹Department of Physiology, University of North Carolina School of Medicine, Chapel Hill, N. C, USA

,

Frieda A O’Hanlon

¹Department of Physiology, University of North Carolina School of Medicine, Chapel Hill, N. C, USA

,

W. L Black

¹Department of Physiology, University of North Carolina School of Medicine, Chapel Hill, N. C, USA

› Author Affiliations

References
1 Hougie C, Barrow E. M, Graham J. B. Stuart Clotting Defect. I. Segregation of an hereditary hemorrhagic state from the heterogenous group heretofore called "Stable Factor" (SPCA, Proconvertin, Factor VII) deficiency. J. clin. Invest 1957; 36: 485
2 Lewis J. H, Fresh J. W, Ferguson J. H. Congenital Hypoproconvertinemia. Proc. Soc. exp. Biol. (N. Y) 1953; 84: 651
3 Alexander B, Goldstein R, Landwehr G, Cook C. D. Congenital SPCA-Deficiency: A hitherto unrecognized coagulation defect with hemorrhage rectified by serum and serum fractions. J. clin. Invest 1951; 30: 596
4 Bachmann F, Duckert F, Geiger M, Baer P, Koller F. Differentiation of the Factor VII Complex. Studies on the Stuart-Prower Factor. Thromb. Diath. haem 1957; 1: 169
5 Rodman jr. N. F, Barrow E. M, Graham J. B. Diagnosis and Control of the Hemophiloid States with the Partial Thromboplastin Time (PTT) Test. Amer. J. clin. Path 1958; 29: 525
6 Ware A. G, Seegers W. H. Two Stage Procedure for the Quantitative Determination of Prothrombin Concentration. Amer. J. clin. Path 1949; 19: 471
7 Lewis J. H, Ferguson J. H, Fresh J. W, Zucker M. B. Primary Hemorrhagic Disease. J. Lab. clin. Med 1957; 49: 216
8 Ferguson J. H, Johnston jr. C. L, Howell D. A. A Circulating-Inhibitor (Anti-AcG) Specific for the Labile Factor-V of the Blood-Clotting Mechanism. Bloo 1958; 13: 382
9 Sise H. S, Lavelle S. M, Becker R. A Method for Assay of Stuart Factor. Proc. Soc. exp. Biol (N. Y.) 1957; 96: 662
10 Bachmann F, Duckert F, Koller F. The Stuart-Prower Factor Assay and its Clinical Significance. Thromb. Diath. haem 1958; 2: 2
11 Fell C, Johnson J. F, Seegers W. H. Effect of Seitz Filtration on Plasma Trace Proteins Concerned with Blood Coagulation. Amer. J. clin. Path 1954; 24: 153
12 Johnston jr. C. L, Ferguson J. H, O’Hanlon F. A. Surface Activation of Plasma Clotting: A function of Hageman Factor. Proc. Soc. exp. Biol. (N. Y) 1958; 99: 197
13 Owren P. A. New Clotting Factors. Trans. 5th Conf. Blood Clotting and Allied Problems. Josiah Macy, jr. Foundation: New York; 1952: p. 92

The Fate of Factor VII and Stuart Factor During the Clotting of Normal Blood [*)]

The Fate of Factor VII and Stuart Factor During the Clotting of Normal Blood ^[*)]